DE102004039537A1 - Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes - Google Patents

Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes Download PDF

Info

Publication number
DE102004039537A1
DE102004039537A1 DE102004039537A DE102004039537A DE102004039537A1 DE 102004039537 A1 DE102004039537 A1 DE 102004039537A1 DE 102004039537 A DE102004039537 A DE 102004039537A DE 102004039537 A DE102004039537 A DE 102004039537A DE 102004039537 A1 DE102004039537 A1 DE 102004039537A1
Authority
DE
Germany
Prior art keywords
matrix
collagen
skin
fibroblasts
equivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102004039537A
Other languages
German (de)
English (en)
Inventor
August Prof. Dr. Bernd
Wolfgang Prof. Dr. Frieß
Karsten Rüdiger Dr. Mewes
Martina Raus
Henriette Bendz
Stefan Prof. Dr. Kippenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phenion GmbH and Co KG
Original Assignee
Phenion GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenion GmbH and Co KG filed Critical Phenion GmbH and Co KG
Priority to DE102004039537A priority Critical patent/DE102004039537A1/de
Priority to JP2007525228A priority patent/JP2008508968A/ja
Priority to PCT/EP2005/008478 priority patent/WO2006018147A2/de
Priority to AT05784392T priority patent/ATE460950T1/de
Priority to EP05784392A priority patent/EP1778307B1/de
Priority to DE502005009240T priority patent/DE502005009240D1/de
Priority to CNA2005800273347A priority patent/CN101001652A/zh
Publication of DE102004039537A1 publication Critical patent/DE102004039537A1/de
Priority to US11/705,674 priority patent/US20070269792A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE102004039537A 2004-08-13 2004-08-13 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes Withdrawn DE102004039537A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE102004039537A DE102004039537A1 (de) 2004-08-13 2004-08-13 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes
JP2007525228A JP2008508968A (ja) 2004-08-13 2005-08-05 皮膚等価物を製造するための架橋コラーゲンマトリックス
PCT/EP2005/008478 WO2006018147A2 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines hautäquivalentes
AT05784392T ATE460950T1 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines hautäquivalentes
EP05784392A EP1778307B1 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines haut[quivalentes
DE502005009240T DE502005009240D1 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines hautäquivalentes
CNA2005800273347A CN101001652A (zh) 2004-08-13 2005-08-05 生产皮肤替代物的交联胶原基质
US11/705,674 US20070269792A1 (en) 2004-08-13 2007-02-13 Cross-linked collagen matrix for producing a skin equivalent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004039537A DE102004039537A1 (de) 2004-08-13 2004-08-13 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes

Publications (1)

Publication Number Publication Date
DE102004039537A1 true DE102004039537A1 (de) 2006-02-23

Family

ID=35677672

Family Applications (2)

Application Number Title Priority Date Filing Date
DE102004039537A Withdrawn DE102004039537A1 (de) 2004-08-13 2004-08-13 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes
DE502005009240T Expired - Lifetime DE502005009240D1 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines hautäquivalentes

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE502005009240T Expired - Lifetime DE502005009240D1 (de) 2004-08-13 2005-08-05 Vernetzte kollagenmatrix zur herstellung eines hautäquivalentes

Country Status (7)

Country Link
US (1) US20070269792A1 (cg-RX-API-DMAC7.html)
EP (1) EP1778307B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008508968A (cg-RX-API-DMAC7.html)
CN (1) CN101001652A (cg-RX-API-DMAC7.html)
AT (1) ATE460950T1 (cg-RX-API-DMAC7.html)
DE (2) DE102004039537A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006018147A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468307A1 (de) 2010-12-23 2012-06-27 Dr. Suwelack Skin & Health Care AG Degradationsstabilisierte, biokompatible Collagenmatrices
WO2021121805A1 (de) * 2019-12-19 2021-06-24 Henkel Ag & Co. Kgaa Gewebetechnologisch unterstützte rekonstruktion einer ekkrine schweissdrüse

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006006461A1 (de) * 2006-02-10 2007-08-23 Phenion Gmbh & Co. Kg Hautmodell mit dendritischen Zellen
US8105380B2 (en) 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
DE102007044093A1 (de) 2007-09-14 2009-03-19 Phenion Gmbh & Co. Kg Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben
FR2957089A1 (fr) * 2010-03-05 2011-09-09 Immunosearch Methode d'evaluation du potentiel sensibilisant d'un compose test
JP5595164B2 (ja) * 2010-07-30 2014-09-24 株式会社 資生堂 真皮黄色化の評価モデル
DE102012223061A1 (de) 2012-12-13 2014-06-18 Henkel Ag & Co. Kgaa Altershautmodell
WO2015166455A1 (en) 2014-04-30 2015-11-05 Fondazione Istituto Italiano Di Tecnologia Method for producing a totally endogenous bioengineered tissue and tissue obtained thereby
US11041146B2 (en) 2014-11-04 2021-06-22 Masakazu Kurita Cell having ability to form stratified epithelial tissue, and method for producing same
CN105087381A (zh) * 2015-08-28 2015-11-25 深圳爱生再生医学科技有限公司 3d免疫细胞培养支架及其制备方法
KR20170055791A (ko) * 2015-11-12 2017-05-22 한국과학기술연구원 인 비트로 3d 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법
JP2017112998A (ja) * 2015-12-18 2017-06-29 富士フイルム株式会社 細胞積層体、生体移植材料、表皮の分化状態の評価方法及び細胞積層体の製造方法、並びにインスリン様成長因子−1産生促進剤
DE102016206862A1 (de) 2016-04-22 2017-10-26 Henkel Ag & Co. Kgaa In-vitro Vollhautmodell, enthaltend dreidimensionale Zellkulturmodelle der Schweißdrüse
US20220016321A1 (en) * 2018-12-13 2022-01-20 Ohio State Innovation Foundation Dermal substitutes and engineered skin with rete ridges
EP3991797A4 (en) * 2019-09-17 2023-06-14 Toppan Inc. CELL STRUCTURE AND METHODS OF PRODUCTION THEREOF
WO2022056131A2 (en) * 2020-09-11 2022-03-17 The Trustees Of Columbia University In The City Of New York Wearable engineered human skin and systems and methods for making the same
CN113201481B (zh) * 2021-04-19 2023-10-13 清华大学深圳国际研究生院 皮肤微球及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925924A (en) * 1984-03-27 1990-05-15 University Of Medicine And Dentistry Of New Jersey Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof
CA2080693C (en) * 1990-04-24 2001-11-27 Mark Eisenberg Composite living skin equivalents
CA2119064A1 (en) * 1993-03-17 1994-09-18 Richard A. Berg Dermal-epidermal in vitro test system
JP2858087B2 (ja) * 1994-09-19 1999-02-17 グンゼ株式会社 組織培養用基材及び組織培養法
US5658190A (en) * 1995-12-15 1997-08-19 Micron Technology, Inc. Apparatus for separating wafers from polishing pads used in chemical-mechanical planarization of semiconductor wafers
FR2743817B1 (fr) * 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
US5963489A (en) * 1998-03-24 1999-10-05 International Business Machines Corporation Method and apparatus for redundancy word line replacement in a repairable semiconductor memory device
JP2000125855A (ja) * 1998-10-21 2000-05-09 Gunze Ltd 人工皮膚
FR2809313B1 (fr) * 2000-05-26 2005-11-18 Coletica Procedes de preparation de nouveaux supports a base de collagene pour l'ingenieurie tissulaire et biomateriaux obtenus
ATE308610T1 (de) * 2000-05-31 2005-11-15 Fraunhofer Ges Forschung Dreidimensionales hautmodell
US6974697B2 (en) * 2001-03-02 2005-12-13 Stratech Corporation Skin substitutes with improved barrier function
US7741116B2 (en) * 2002-03-06 2010-06-22 University Of Cincinnati Surgical device for skin therapy or testing

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468307A1 (de) 2010-12-23 2012-06-27 Dr. Suwelack Skin & Health Care AG Degradationsstabilisierte, biokompatible Collagenmatrices
EP2789352A1 (de) 2010-12-23 2014-10-15 MedSkin Solutions Dr. Suwelack AG Degradationsstabilisierte, biokompatible Collagenmatrices
WO2021121805A1 (de) * 2019-12-19 2021-06-24 Henkel Ag & Co. Kgaa Gewebetechnologisch unterstützte rekonstruktion einer ekkrine schweissdrüse

Also Published As

Publication number Publication date
EP1778307A2 (de) 2007-05-02
JP2008508968A (ja) 2008-03-27
CN101001652A (zh) 2007-07-18
DE502005009240D1 (de) 2010-04-29
EP1778307B1 (de) 2010-03-17
WO2006018147A3 (de) 2006-06-15
US20070269792A1 (en) 2007-11-22
ATE460950T1 (de) 2010-04-15
WO2006018147A2 (de) 2006-02-23

Similar Documents

Publication Publication Date Title
EP1290145B1 (de) Dreidimensionales hautmodell
EP1778307B1 (de) Vernetzte kollagenmatrix zur herstellung eines haut[quivalentes
DE60204352T2 (de) Haut/haar-äquivalent mit rekonstruierten papillen
DE69927600T2 (de) Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung
EP2302035B1 (en) A method of producing a cultured skin device
DE60036047T2 (de) Gealtelter Haut-äquivalent, deren Herstellungsverfahren und Verwendungen
Phang et al. Advancements in extracellular matrix-based biomaterials and biofabrication of 3D organotypic skin models
EP3445846A1 (de) IN-VITRO VOLLHAUTMODELL, ENTHALTEND DREIDIMENSIONALE ZELLKULTURMODELLE DER SCHWEIßDRÜSE
DE10196234B4 (de) Verfahren zur Herstellung eines Verbundprodukts aus Kollagen für die Gewebebildung und seine Verwendung
JP2022536506A (ja) 3dバイオプリントされた皮膚組織モデル
WO2001068811A2 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
EP2029186B1 (de) Isoliertes naturidentisches kollagen
WO2007090575A1 (de) Hautmodell mit dendritischen zellen
CN109722410B (zh) 一种3d全层皮肤模型及用于其形成的培养基、制备方法
DE102007040370A1 (de) Kollagenhaltiger Zellträger
DE10062623B4 (de) Dreidimensionales Hautmodell
WO2001092476A2 (de) In vitro-gewebetestsystem
DE10327879A1 (de) Rekonstruierte dermale Papille
Alonzo Engineering Cardiac Tissues with Three-Dimensional Bioprinting for Biomedical Applications
DE102015222277B4 (de) Verfahren zur Herstellung eines dreidimensionalen Zellkulturmodells der Schweißdrüse, insbesondere der humanen Schweißdrüse
HK1101320A (en) Cross-linked collagen matrix for producing a skin equivalent

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: PHENION GMBH & CO. KG, 40225 DUESSELDORF, DE

8139 Disposal/non-payment of the annual fee